Microsoft Corp (MSFT) 57.67 $MSFT Videogame Stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Microsoft Corp (MSFT) 57.67 $MSFT

Videogame Stock Roundup: SINA to Distribute Weibo Stock, Pokemon Go Generates $440M in Revenues
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 9:50AM CDT
Last week, SINA Corp (SINA) announced that it will distribute its Weibo stock to its shareholders on pro rata basis and media reports revealed a staggering $440 million in revenues earned by Nintendo's Pokemon Go in less than two months.
TTWO: 44.70 (+0.94), SINA: 81.88 (+3.13), WB: 49.54 (+0.52), NTES: 214.91 (-1.00), GLUU: 2.32 (+0.02), MSFT: 57.67 (+0.08)

Microsoft Vends MSN China to XiChuang, Focuses on Cloud
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 9:28AM CDT
Microsoft Corporation (MSFT) recently announced the divestment of its MSN China web portal to XiChuang Technology.
AVID: 9.12 (+0.08), AZPN: 45.92 (+0.30), BLOX: 22.74 (+0.60), MSFT: 57.67 (+0.08)

Next Resistance Level for Microsoft (MSFT) is $58.28
Comtex SmarTrend(R) - Fri Sep 02, 9:05AM CDT
Microsoft (NASDAQ:MSFT) has opened bullishly above the pivot of $57.47 today and has reached the first level of resistance at $57.94. Investors may be interested in a cross of the next upside pivot targets of $58.28 and $59.09.
MSFT: 57.67 (+0.08)

Post Earnings Coverage as Salesforce Revenue Surges 25 Percent
ACCESSWIRE - Fri Sep 02, 8:20AM CDT
LONDON, UK / ACCESSWIRE / September 2, 2016 / Active Wall St. announces its post-earnings coverage on salesforce.com, inc. (NYSE: CRM). The company reported second quarter fiscal 2017 (Q2 FY17) financial results on August 31, 2016. The Cloud software maker reported a 25% increase in revenue as demand for its internet based sales and marketing software rose; however salesforce.com provided a disappointing forecast for the upcoming quarter. Register with us now for your free membership at: http://www.activewallst.com/register/.
LNKD: 192.80 (+0.07), MSFT: 57.67 (+0.08), CRM: 75.10 (-0.81)

Can Alphabet Win Over PayPal to Boost Share in Cloud?
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 10:26AM CDT
Alphabet Inc. (GOOGL) is reportedly on the verge of a big win in the cloud infrastructure services market that is dominated by Amazon.com, Inc. (AMZN) with Microsoft Corporation (MSFT) as runner-up.
AMZN: 772.44 (+1.82), PYPL: 37.07 (+0.24), GOOGL: 796.87 (+5.47), MSFT: 57.67 (+0.08)

4 Stocks to Watch After the Market Closes Today
ESTMZ - Wed Aug 31, 8:00AM CDT
Salesforce ( CRM ): Acquisitions have been a key part of the company’s growth strategy. Over the past few years new acquisitions and partnerships have helped Salesforce improve and build its native offerings. Year to date the company has completed 9...
DSW: 23.86 (+0.15), SPY: 218.37 (+0.98), BOX: 14.14 (+0.16), LNKD: 192.80 (+0.07), SCVL: 26.17 (-0.01), FIVE: 43.40 (-0.65), MSFT: 57.67 (+0.08), CRM: 75.10 (-0.81)

Want to Get Virtual? Here's How to Invest in the Cloud
Madeleine Johnson - Zacks Investment Research - Tue Aug 30, 5:27PM CDT
Cloud computing is made up of more than just our favorite smartphone apps and virtual assistants. It's a booming market, and companies from every facet of the industry either have a cloud computing product on the market, or are working diligently to get one there. Here's how to invest.
NFLX: 97.38 (unch), AMZN: 772.44 (+1.82), IBM: 159.55 (+0.01), FB: 126.51 (+0.34), GOOGL: 796.87 (+5.47), SKYY: 33.87 (+0.15), INTC: 36.08 (+0.06), MSFT: 57.67 (+0.08), AAPL: 107.73 (+1.00), ORCL: 41.25 (+0.09), CSCO: 31.83 (+0.25), CRM: 75.10 (-0.81)

Zuckerberg's Home AI Advances Facebook's Technology
David Bartosiak - Zacks Investment Research - Tue Aug 30, 3:16PM CDT
Zuckerberg's personal project this year was a digital assistant to automate his house.
AMZN: 772.44 (+1.82), FB: 126.51 (+0.34), GOOGL: 796.87 (+5.47), MSFT: 57.67 (+0.08)

Dropbox IPO Could Be Its Swan Song
Lior Ronen - Amigobulls - Tue Aug 30, 1:24AM CDT
A Dropbox IPO will be the swan song for the company, marking the beginning of the end for the former glorious cloud storage vendor.
BOX: 14.14 (+0.16), MSFT: 57.67 (+0.08), GOOG: 771.46 (+2.68), AAPL: 107.73 (+1.00)

Tech Stock Roundup: AMZN Vehicles & Music, GOOGL Fiber
Sejuti Banerjea - Zacks Investment Research - Mon Aug 29, 10:04AM CDT
Amazon (AMZN) launched Vehicles and was the subject of rumors about music streaming plans and retail stores and Alphabet's (GOOGL) Google Fiber was ordered to cut costs.
AMZN: 772.44 (+1.82), FB: 126.51 (+0.34), GOOGL: 796.87 (+5.47), TWTR: 19.55 (+0.05), INTC: 36.08 (+0.06), MSFT: 57.67 (+0.08), AAPL: 107.73 (+1.00)

Will SAP's HANA, Cloud Offerings Offset Low Client Spending?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:48AM CDT
We have issued an updated research report on SAP.
AMZN: 772.44 (+1.82), SAP: 89.64 (+1.17), IBM: 159.55 (+0.01), MSFT: 57.67 (+0.08)

Microsoft Corporation Stock On Course To Breach $65
Ravi Bala - Amigobulls - Mon Aug 29, 2:15AM CDT
A number of technical indicators indicate that Microsoft Corporation (NASDAQ:MSFT) stock could be headed higher than the $60 target price of wall street.
MSFT: 57.67 (+0.08)

Should You Buy Microsoft Corporation Stock Heading Into 2017?
Shudeep Chandrasekhar - Amigobulls - Sat Aug 27, 12:00AM CDT
Microsoft Corporation (NASDAQ:MSFT) has many potential upsides heading into 2017. Is It time to buy Microsoft Corporation stock.
MSFT: 57.67 (+0.08)

Autodesk (ADSK) Q2 Loss Lower than Expected, Guides Well
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 8:13AM CDT
Autodesk Inc. (ADSK) reported second-quarter fiscal 2017 adjusted loss of 10 cents a share, which compared favorably with the Zacks Consensus Estimate of a loss of 30 cents.
AMZN: 772.44 (+1.82), MSFT: 57.67 (+0.08), ADBE: 103.57 (+0.67), ADSK: 68.01 (+0.64)

Microsoft Bundles Productivity Apps with Lenovo Devices
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:15AM CDT
Microsoft Corporation (MSFT) has added Lenovo to the list of companies with which it has patent cross-licensing deals.
MSFT: 57.67 (+0.08), CALD: 19.93 (+0.72), DST: 123.38 (+1.71), DWCH: 6.84 (-0.11)

Texas Instruments & Intel: Two Top Semiconductor Stocks
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:18PM CDT
We have evaluated two semiconductor companies that have demonstrated a remarkable share price performance this year.
TXN: 69.68 (-0.02), INTC: 36.08 (+0.06), MSFT: 57.67 (+0.08)

What's in the Cards for Splunk (SPLK) in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:26AM CDT
Splunk Inc. (SPLK) is scheduled to release second-quarter fiscal 2017 results on Aug 25
DLTR: 83.11 (-0.07), IBM: 159.55 (+0.01), SPLK: 59.39 (+1.20), MSFT: 57.67 (+0.08)

Tech Data (TECD) Q2 Earnings: What to Expect this Time?
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:52AM CDT
Tech Data Corp. (TECD) is set to release second-quarter fiscal 2017 results on Aug 27.
DLTR: 83.11 (-0.07), TECD: 73.33 (-0.01), MSFT: 57.67 (+0.08), SWHC: 27.69 (-1.89)

The Zacks Analyst Blog Highlights: Intel, Facebook, Alphabet, Oracle and Microsoft
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:30AM CDT
The Zacks Analyst Blog Highlights: Intel, Facebook, Alphabet, Oracle and Microsoft
FB: 126.51 (+0.34), GOOGL: 796.87 (+5.47), MSFT: 57.67 (+0.08), INTC: 36.08 (+0.06), ORCL: 41.25 (+0.09)

The Zacks Analyst Blog Highlights: Sony, Microsoft and Nintendo
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:30AM CDT
The Zacks Analyst Blog Highlights: Sony, Microsoft and Nintendo
SNE: 32.64 (+0.50), MSFT: 57.67 (+0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading